Regrettably, pharmacological treatment including either insulin, or oral hypoglycemic agents, such as metformin or SU, turned out to be ineffective in this form of MODY, probably due to the fact that the switch-on of the counter-regulatory response occurs at higher glucose level than in healthy subjects [14, 15]. This evidence concerns the gene INS and MODY.